Jane Street Group, LLC Anavex Life Sciences Corp. Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	BUY	$9.74 - $17.69 $323,368 - $587,308	33,200 Added 16.23%	237,700 $2.93 Million
Q4 2021 Feb 15, 2022	SELL	$16.88 - $23.31 $72,584 - $100,233	-4,300 Reduced 2.06%	204,500 $3.55 Million
Q3 2021 Nov 16, 2021	SELL	$16.82 - $25.75 $2.64 Million - $4.04 Million	-156,800 Reduced 42.89%	208,800 $3.75 Million
Q2 2021 Aug 16, 2021	BUY	$10.16 - $28.86 $3.22 Million - $9.14 Million	316,800 Added 649.18%	365,600 $8.36 Million
Q1 2021 May 18, 2021	BUY	$5.17 - $16.13 $40,843 - $127,426	7,900 Added 19.32%	48,800 $730,000
Q4 2020 Feb 17, 2021	BUY	$4.01 - $7.58 $164,009 - $310,022	40,900 New	40,900 $221,000

152

26.5M

674K

811K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $443M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.